both postdoctoral fellows in Lim’s lab in the Department of Cellular & Molecular Pharmacology, and in the Howard Hughes Medical Institute. Co-authors include Jason S. Park, and Sergio G. Peisajovich (now at University of Toronto), also with the department and HHMI; and Ethan ...
"This points toward a day when doctors may treat their patients with drugs that have been individually tailored to the idiosyncracies of their own disease," first author Bin Chen, assistant professor with the Institute for Computational Health Sciences (ICHS) and the Department of Pediatrics at ...
as an educational tool, UCSF faculty from the Department of Emergency Medicine have spearheaded implementation of software used by physicians-in-training to respond to simulated clinical
As an assistant professor in the Division of Occupational and Environmental Medicine at University of California, San Francisco, Dr. Carisa Harris-Adamson performs research that helps industries develop better ergonomic techniques that protect their workers. Her department’s research includes pinpointing a...
Dr. Li is a Professor in the Department of Biochemistry and Biophysics at UCSF and the director of the UCSF Hillblom Center for the Biology of Aging. He received his BS in Physics from Peking University and Ph. D. in Theoretical Physics from MIT. He is a Changjiang Lecture Professor at ...
Primary Care for Transgender Patients - Ucsf初级保健为变性患者-加州大学旧金山分校.ppt,Primary Care for Transgender Patients Lori Kohler, MD Department of Family and Community Medicine University of California, San Francisco Primary Care for Transgender P
Blackburn remained at Berkeley until 1990, when she became a professor in the department of biochemistry and biophysics and in the department of microbiology and immunology at the University of California,San Francisco(UCSF). From 1993 to 1999 she also was chair of the department of microbiology ...
The defense department also supported work at the Berkeley-based biotech XOMA Ltd., to develop a therapy based on the UCSF research and bring it to clinical trials. On May 3, 2011, the National Institutes of Health informed XOMA that they were initiating a phase 1 clinical trial of the tri...
(now at University of Toronto), also with the department and HHMI; and Ethan Corcoran (now at Northwest Permanente NC) and Arthur Weiss, with HHMI and the UCSF Department of Medicine. The team is also part of the UCSF Cell Propulsion Laboratory and the UCSF Center for Systems and Synthetic...